Gastrojejunostomy followed by induction chemotherapy for incurable gastric cancer with outlet obstruction

被引:0
作者
Yasuhiro Okumura [1 ]
Manabu Ohashi [1 ]
Souya Nunobe [2 ]
Tomohiro Iwanaga [1 ]
Tatsuo Kanda [3 ]
Yoshiaki Iwasaki [1 ]
机构
[1] Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
[2] Department of Gastrointestinal Surgery, Tokyo University Hospital
[3] Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences
关键词
Gastric cancer; Outlet obstruction; CY1; Laparoscopy-assisted gastrojejunostomy; S-1 plus cisplatin;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100214 ;
摘要
A 72-year-old male gastric cancer patient with outlet obstruction underwent laparoscopic exploration. The examination disclosed intraperitoneal free cancer cells with no overt peritoneal, lymphatic, or hepatic metastasis. The patient underwent laparoscopy-assisted gastroje-junostomy (LAGJ) and started chemotherapy with S-1 plus cisplatin on postoperative day 13. Three course of the chemotherapy shrank the tumor markedly. Then, the patient underwent gastrectomy with a curative intent. Laparotomy revealed no intraperitoneal free cancer cells, and microscopically complete resection was achieved. The patient received S-1 chemotherapy as postoperative adjuvant treatment for 1 year, and is still alive with no evidence of peritoneal recurrence. LAGJ followed by S-1 plus cisplatin is one of the optional treatments that should be considered for patients with outlet obstruction as it may widen opportunities for potentially curative resection.
引用
收藏
页码:4367 / 4370
页数:4
相关论文
共 9 条
[1]   A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study) [J].
Kodera, Y. ;
Ito, S. ;
Mochizuki, Y. ;
Kondo, K. ;
Koshikawa, K. ;
Suzuki, N. ;
Kojima, H. ;
Kojima, T. ;
Matsui, T. ;
Takase, T. ;
Tsuboi, K. ;
Fujiwara, M. ;
Nakao, A. .
EJSO, 2009, 35 (11) :1158-1163
[2]  
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial[J] . Wasaburo Koizumi,Hiroyuki Narahara,Takuo Hara,Akinori Takagane,Toshikazu Akiya,Masakazu Takagi,Kosei Miyashita,Takashi Nishizaki,Osamu Kobayashi,Wataru Takiyama,Yasushi Toh,Takashi Nagaie,Seiichi Takagi,Yoshitaka Yamamura,Kimihiko Yanaoka,Hiroyuki Orita,Masahiro Takeuchi.Lancet Oncology . 2008 (3)
[3]   Gastrojejunostomy as induction treatment for S-1-based chemotherapy in patients with incurable gastric cancer [J].
Ohashi, Manabu ;
Kanda, Tatsuo ;
Hirota, Masaki ;
Kobayashi, Takashi ;
Yajima, Kazuhito ;
Kosugi, Shin-ichi ;
Hatakeyama, Katsuyoshi .
SURGERY TODAY, 2008, 38 (12) :1102-1107
[4]   Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer [J].
Nakagawa, Satoru ;
Nashimoto, Atsushi ;
Yabusaki, Hiroshi .
GASTRIC CANCER, 2007, 10 (01) :29-34
[5]   Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination [J].
Satoh S. ;
Hasegawa S. ;
Ozaki N. ;
Okabe H. ;
Watanabe G. ;
Nagayama S. ;
Fukushima M. ;
Takabayashi A. ;
Sakai Y. .
Gastric Cancer, 2006, 9 (2) :129-135
[6]  
Laparoscopic gatrojejunostomy for palliation of gastric outlet obstruction in unresectable gastric cancer[J] . Y.-B. Choi.Surgical Endoscopy . 2002 (11)
[8]  
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1<ce:hsp sp="0.25"/>M tegafur–0.4<ce:hsp sp="0.25"/>M gimestat–1<ce:hsp sp="0.25"/>M otastat potassium) in advanced gastric cancer patients[J] . Y Sakata,A Ohtsu,N Horikoshi,K Sugimachi,Y Mitachi,T Taguchi.European Journal of Cancer . 1998 (11)
[9]   Gastric carcinoma with pyloric stenosis [J].
Watanabe, A ;
Maehara, Y ;
Okuyama, T ;
Kakeji, Y ;
Korenaga, D ;
Sugimachi, K .
SURGERY, 1998, 123 (03) :330-334